·Key member of the executive team that successfully marketed and sold the company to a strategic buyer in September 2008 generating a 75% increase to preannouncement stock price for shareholders. Provided seamless transition by training SAES-Getters executives to customer base, technical and manufacturing capabilities, engineering projects and pipeline.
·Envisioned company corporate strategy, initiated and spearheaded M&A activities resulting in the company’s first and immediately accretive acquisition in November 2004, a privately held high-end catheter extrusion company.
·Go-to expert on technology, medical market and device applications to support the executive, sales & marketing and engineering teams to hone in on a profitable niche market and bring distinctive value to the customers in it.
·Led the diversification and expansion of the company global activities by identifying, qualifying and championing activities and follow up for the products generating in excess of 70% of company yearly revenues.
·Directed a successful 2-year R&D collaboration program leading to the execution of an exclusive license agreement with a U.K. technology company for an anti-proliferative stent coating to expand the company’s current bare nitinol stent platform offering into $1 billion premium market segment.
·Reduced IP legal cost by more than $140K/year by realigning and streamlining company’s IP portfolio.